COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,705 Articles (22,913 medRxiv, 8,792 bioRxiv)

Most recent first Previous |  Page 14: Articles 131-140  | Next

Rationale and Design of RECOVER-ENERGIZE: A Platform Clinical Trial of Interventions for Exercise Intolerance With and Without Post-exertional Malaise in Long COVID
Friedly, J., Bateman, L., Berdan, L. G., Casaburi, R., Erdmann, N., Felker, G. M., Itchon-Ramos, N., Keteyian, S. J., MacIntyre, N. R., OBrien, L., Reist, C., Rossiter, H. B., Silverstein, A. P., Taylor, E., Pike Welch, H., Yanez, N. D., Zimmerman, K. O., Make, B.
10.64898/2026.06.02.26354455 — Posted: 2026-06-03
Simple cumulative weighting of routine surveillance data identifies epidemic wave origins more accurately than a large language model: evidence from eight COVID-19 waves in Japan
Nakagawa, S., Yamamoto, A.
10.64898/2026.06.02.26354691 — Posted: 2026-06-03
SARS-CoV-2 BA.3.2.2 is more evasive of neutralization by sera from young children
Wu, M., Hong, H., Guo, Y., Daniel, K., Hisner, R., Johnson, M. C., Gordon, A., Ho, D. D., Mellis, I. A.
10.64898/2026.06.01.728533 — Posted: 2026-06-03
Chronic cocaine exposure negatively impacts Long-COVID-like outcomes produced by the SARS-CoV-2 spike protein in the rat
Davis, S. E., Stern, D. R., Inan, S., Vu, E., Lopez, D., Anwuri, F., Ghilotti, M. G., Meissler, J. J., Unterwald, E. M.
10.64898/2026.06.02.729575 — Posted: 2026-06-02
A Viral Mutation Profiling and Discovery Strategy for Sensitive Multiplex Detection of Viruses and Variants in Saliva by Proteomics
Zhang, Y., Shortreed, M., Timperman, A. T.
10.64898/2026.05.30.729008 — Posted: 2026-06-02
Structural Basis for Inhibition of the HKU5-CoV Main Protease by Clinical SARS-CoV-2 Protease Inhibitors
Kim, H., Ahn, J., Lee, J., Jung, S., Kim, J. W., Kim, B., Ha, N.-C., Jo, I.
10.64898/2026.06.01.729201 — Posted: 2026-06-02
Data aggregation and mechanistic modeling enable dose-response analysis of SARS-CoV-1 in non-human primates
Lee, P. C., Snedden, C. E., Morris, D. H., Lloyd-Smith, J.
10.64898/2026.06.01.729195 — Posted: 2026-06-01
Immune context unmasks regulatory effects of Neanderthal and Denisovan introgression
Li, Z., kerner, g., Mendoza-Revilla, J., Inoue, F., Fishilevich, S., Patin, E., Gokhman, D., Quintana-Murci, L., Rotival, M.
10.64898/2026.05.29.727880 — Posted: 2026-06-01
A Monoclonal Antibody Panel to Track Ongoing Antigenic Evolution of SARS-CoV-2 Variants
Wu, M., Hong, H., Chong, S., Yu, J., Mellis, I. A., Huang, C.-Y., Wang, Q., Huang, Y., Guo, Y., Ho, D. D.
10.64898/2026.05.29.728770 — Posted: 2026-06-01
Towards understanding of NK cell antigenic specificity
Ustiuzhanina, M. O., Shagina, I. A., Nikitin, E., Klimuk, E., Britanova, O., Ventura-Carmenate, Y., Kovalenko, E., Chudakov, D. M.
10.64898/2026.05.29.728791 — Posted: 2026-06-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).